Alzheimer's disease, the most common form of dementia, is considered a disease of old age. But an unlikely group of 400,000 Americans are 'destined' to be diagnosed as young as 40, experts warn.

Europe risks ceding its leadership in rare disease innovation unless it urgently recalibrates its incentive framework, warns Enrico Piccinini, Senior Vice President EU & International at Chiesi.